Natera Tech Stack

Cell-free DNA diagnostics platform across oncology, prenatal, and organ health

Biotechnology Research Austin, Texas 5,001–10,000 employees Founded 2004 Public Company

Natera operates a large, regulated diagnostics business spanning oncology, women's health, and organ transplant markets, with labs in Austin, San Carlos, and Boulder certified under CLIA, CAP, and ISO standards. The tech stack reflects dual operational needs: sequencing hardware (Illumina, PacBio) feeding bioinformatics pipelines (Python, Pandas, scikit-learn) deployed on AWS and Kubernetes, plus clinical-operational tools (Salesforce, Skedulo). Active adoption of Signatera (their own ctDNA assay platform) and RAG patterns, combined with hiring velocity accelerating across healthcare, sales, and engineering roles, indicates a push to scale oncology diagnostics and reduce manual clinical workflows.

Tech Stack 148 technologies

Core StackSalesforce Python Java Spring Kafka React Angular Nest.js GraphQL Kubernetes AWS TypeScript Node.js Helm Terraform PostgreSQL Pandas NumPy scikit-learn Illumina PacBio SQL Tecan Skedulo Google Workspace Signatera PowerPoint Excel Gmail AWS ECS+117 more

AdoptingRAG Oracle Database Signatera Altera

ReplacingNetSuite

What Natera Is Building

◆Challenges

Expanding market adoption
Clinical workflow improvement
Increasing adoption of signatera
Reducing equipment downtime
Driving market development
Technical debt reduction
Patient volume growth
Improving operating efficiency
Increasing test sample volume
Expanding oncology diagnostics sales

▲Active Projects

New product launches
Emr integrations
Ai transformation
Clinical development of ctdna-based diagnostics
Strategic territory plan
Process validation for oncology assay
Early cancer detection software portfolio
Care pathway development
Manufacturing scale up
Automation for new assays production workflows

Hiring Activity

Accelerating250 roles · 110 in 30d

Department

Healthcare

Sales

Research

Engineering

Ops

Product

Data

Marketing

Seniority

Senior

Mid

Junior

Director

Manager

Lead

Principal

Staff

Notable leadership hires: Medical Director, Laboratory Director, Transplant Director, Strategic Accounts Director

Company intelligence

Find more companies like Natera by tech stack, pain points and active projects

Get started free

About Natera

Natera is a CLIA and CAP-accredited diagnostics company founded in 2004 and headquartered in Austin, Texas, with approximately 5,000–10,000 employees. The company manufactures cell-free DNA tests across three clinical domains: non-invasive prenatal testing, single-gene and carrier screening, and organ transplant monitoring. Revenue and market presence are supported by over 325 peer-reviewed publications. Operations span three regulated laboratories and are expanding into early cancer detection (ctDNA-based diagnostics) and downstream software platforms. Current strategic priorities include scaling sample volumes, reducing equipment downtime, improving clinical workflow integration with EMR systems, and expanding oncology diagnostics adoption in new territories.

HeadquartersAustin, Texas

Company Size5,001–10,000 employees

Founded2004

Hiring MarketsUnited States, Japan

Frequently Asked Questions

What is Natera's technology platform?

Natera operates cell-free DNA testing across oncology, prenatal, and organ health using Illumina and PacBio sequencers, Python-based bioinformatics (Pandas, scikit-learn), and AWS infrastructure. The company is actively scaling its Signatera ctDNA assay platform for cancer detection.

Where are Natera's laboratories located?

Natera operates CLIA/CAP-accredited labs in Austin, Texas; San Carlos, California; and Boulder, Colorado (through subsidiary Foresight Diagnostics). The company also hires in Japan.